Moyra E Mortby1, Zahinoor Ismail2, Kaarin J Anstey1. 1. Centre for Research on Ageing,Health and Wellbeing,Research School of Population Health,The Australian National University,Canberra,Australia. 2. Departments of Psychiatry and Clinical Neurosciences,Mathison Centre for Mental Health Research & Education,Ron and Rene Centre for Healthy Brain Aging Research,Hotchkiss Brain Institute,University of Calgary,Calgary,Canada.
Abstract
BACKGROUND: A dearth of population-based epidemiological research examines neuropsychiatric symptom (NPS) in sub-clinical populations across the spectrum from normal aging to mild cognitive impairment (MCI). The construct of mild behavioral impairment (MBI) describes the emergence of sustained and impactful NPS in advance of or in combination with MCI. This is the first epidemiological study to operationalize the recently published diagnostic criteria for MBI and determine prevalence estimates across the spectrum from cognitively normal to MCI. METHODS: MBI was assessed in 1,377 older (age range 72-79 years; 52% male; MCI ;= 133; cognitively normal, but-at-risk = 397; cognitively healthy = 847). MBI was assessed in accordance with the ISTAART-AA diagnostic criteria for MBI using the neuropsychiatric inventory. RESULTS: 34.1% of participants met the criteria for MBI. High prevalence of MBI across the cognitive spectrum was reported (48.9% vs. 43.1% vs. 27.6%). Irrespective of level of cognitive impairment, impulse dyscontrol (33.8% vs. 28.7% vs. 17.2%) and decreased motivation (32.3% vs. 26.2% vs. 16.3%) were the most frequently met MBI domains. MBI was more prevalent in men (χ2 = 4.98, p = 0.026), especially the domains of decreased motivation and impulse dyscontrol. CONCLUSIONS: This study presents the first population-based prevalence estimates for MBI using the recently published ISTAART-AA diagnostic criteria. Findings indicate relatively high prevalence of MBI in pre-dementia clinical states and amongst cognitively healthy older adults. Findings were gender-specific, with MBI affecting more men than women. Knowing the estimates of these symptoms in the population is essential for understanding and differentiating the very early development of clinical disorders.
BACKGROUND: A dearth of population-based epidemiological research examines neuropsychiatric symptom (NPS) in sub-clinical populations across the spectrum from normal aging to mild cognitive impairment (MCI). The construct of mild behavioral impairment (MBI) describes the emergence of sustained and impactful NPS in advance of or in combination with MCI. This is the first epidemiological study to operationalize the recently published diagnostic criteria for MBI and determine prevalence estimates across the spectrum from cognitively normal to MCI. METHODS: MBI was assessed in 1,377 older (age range 72-79 years; 52% male; MCI ;= 133; cognitively normal, but-at-risk = 397; cognitively healthy = 847). MBI was assessed in accordance with the ISTAART-AA diagnostic criteria for MBI using the neuropsychiatric inventory. RESULTS: 34.1% of participants met the criteria for MBI. High prevalence of MBI across the cognitive spectrum was reported (48.9% vs. 43.1% vs. 27.6%). Irrespective of level of cognitive impairment, impulse dyscontrol (33.8% vs. 28.7% vs. 17.2%) and decreased motivation (32.3% vs. 26.2% vs. 16.3%) were the most frequently met MBI domains. MBI was more prevalent in men (χ2 = 4.98, p = 0.026), especially the domains of decreased motivation and impulse dyscontrol. CONCLUSIONS: This study presents the first population-based prevalence estimates for MBI using the recently published ISTAART-AA diagnostic criteria. Findings indicate relatively high prevalence of MBI in pre-dementia clinical states and amongst cognitively healthy older adults. Findings were gender-specific, with MBI affecting more men than women. Knowing the estimates of these symptoms in the population is essential for understanding and differentiating the very early development of clinical disorders.
Authors: Jeannie-Marie S Leoutsakos; Elizabeth A Wise; Constantine G Lyketsos; Gwenn S Smith Journal: Int J Geriatr Psychiatry Date: 2019-09-02 Impact factor: 3.485
Authors: Ganesh M Babulal; Ling Chen; Jason M Doherty; Samantha A Murphy; Ann M Johnson; Catherine M Roe Journal: J Alzheimers Dis Date: 2022 Impact factor: 4.160
Authors: Sascha Gill; Meng Wang; Pauline Mouches; Deepthi Rajashekar; Tolulope Sajobi; Frank P MacMaster; Eric E Smith; Nils D Forkert; Zahinoor Ismail Journal: Int J Geriatr Psychiatry Date: 2021-04-09 Impact factor: 3.850
Authors: Sascha Gill; Pauline Mouches; Sophie Hu; Deepthi Rajashekar; Frank P MacMaster; Eric E Smith; Nils D Forkert; Zahinoor Ismail Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472
Authors: Penny A Gosselin; Zahinoor Ismail; Peter D Faris; Carmen L Benkoczi; Tammy L Fraser; Steven W Cherry; Tracey I Faulkner; Md Shariful Islam Journal: Can Geriatr J Date: 2019-09-30
Authors: Jung Yun Jang; S Duke Han; Belinda Yew; Anna E Blanken; Shubir Dutt; Yanrong Li; Jean K Ho; Aimée Gaubert; Daniel A Nation Journal: Front Aging Neurosci Date: 2021-06-25 Impact factor: 5.750